These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 18088232)
41. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways. Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521 [TBL] [Abstract][Full Text] [Related]
42. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272 [TBL] [Abstract][Full Text] [Related]
43. Going with the flow: JAK-STAT signaling in JMML. Kalaitzidis D; Gilliland DG Cancer Cell; 2008 Oct; 14(4):279-80. PubMed ID: 18835028 [TBL] [Abstract][Full Text] [Related]
44. Signaling networks regulating cardiac myocyte survival and death. Wagner M; Siddiqui MA Curr Opin Investig Drugs; 2009 Sep; 10(9):928-37. PubMed ID: 19705335 [TBL] [Abstract][Full Text] [Related]
45. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy. Tao W; Wen F; Zhang H; Liu G Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729 [TBL] [Abstract][Full Text] [Related]
46. IFNgamma signaling-does it mean JAK-STAT? Gough DJ; Levy DE; Johnstone RW; Clarke CJ Cytokine Growth Factor Rev; 2008; 19(5-6):383-94. PubMed ID: 18929502 [TBL] [Abstract][Full Text] [Related]
47. Stat5 as a diagnostic marker for leukemia. Lewis RS; Ward AC Expert Rev Mol Diagn; 2008 Jan; 8(1):73-82. PubMed ID: 18088232 [TBL] [Abstract][Full Text] [Related]
48. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway. Himpe E; Kooijman R Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849 [TBL] [Abstract][Full Text] [Related]
49. STAT5 and STAT5 Inhibitors in Hematological Malignancies. Tolomeo M; Meli M; Grimaudo S Anticancer Agents Med Chem; 2019; 19(17):2036-2046. PubMed ID: 31490767 [TBL] [Abstract][Full Text] [Related]
50. Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver. Baltayiannis G; Baltayiannis N; Tsianos EV J BUON; 2008; 13(2):263-5. PubMed ID: 18555475 [TBL] [Abstract][Full Text] [Related]